Myeloid sarcoma
Clinical trials for Myeloid sarcoma explained in plain language.
Never miss a new study
Get alerted when new Myeloid sarcoma trials appear
Sign up with your email to follow new studies for Myeloid sarcoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for kids with leukemia: new drug combo aims to boost remission
Disease control Recruiting nowThis phase 2 trial tests whether adding the targeted drug venetoclax to standard chemotherapy is safe and effective for children and young adults (up to age 22) with newly diagnosed acute myeloid leukemia (AML). The study aims to see if this combination can reduce the amount of c…
Matched conditions: MYELOID SARCOMA
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for kids with AML: gentler chemo combos under trial
Disease control Recruiting nowThis early-phase trial is testing two new chemotherapy combinations for children and young adults with acute myeloid leukemia (AML) who are at intermediate or high risk of relapse. The goal is to see if these combinations are tolerable and can achieve similar or better survival w…
Matched conditions: MYELOID SARCOMA
Early phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug cocktail aims to tackle tough leukemia
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called ziftomenib alongside standard treatments for acute myeloid leukemia (AML) in people with specific gene mutations. About 420 participants with newly diagnosed or relapsed AML will be assigned to one of three treatment a…
Matched conditions: MYELOID SARCOMA
Phase 1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for tough leukemia cases: drug combo trial opens for kids and young adults
Disease control Recruiting nowThis study is for children, teens, and young adults (ages 1 to 39) with acute leukemia that has come back or not gotten better with standard treatments. Researchers are testing whether combining two drugs—venetoclax and Vyxeos—is safe and tolerable. The goal is to find the best d…
Matched conditions: MYELOID SARCOMA
Phase 1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Heart shield: new trial aims to prevent chemo side effects in blood cancer patients
Symptom relief Recruiting nowThis study tests whether a drug called dexrazoxane can protect the heart from damage caused by chemotherapy in people with certain blood cancers, such as acute myeloid leukemia and high-risk myelodysplastic syndrome. About 100 participants will receive dexrazoxane alongside stand…
Matched conditions: MYELOID SARCOMA
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New screening trial aims to match kids with relapsed leukemia to targeted therapies
Knowledge-focused Recruiting nowThis study screens children and young adults up to age 22 whose leukemia has returned or is hard to treat. By testing their blood and bone marrow, doctors can identify specific genetic markers to match them with the most promising experimental treatments. The goal is to build a r…
Matched conditions: MYELOID SARCOMA
Phase 1/2 • Sponsor: PedAL BCU, LLC • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC